Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A selectable marker allows investigation of a nontransforming Epstein-Barr virus mutant.

Journal of virology - 1 May 1992

Marchini A, Cohen J I, Wang F, Kieff E

Abstract excerpt

The derivation of specifically mutated Epstein-Barr virus (EBV) recombinants is dependent on strategies to identify, enumerate, and clone infected B lymphocytes. In recent experiments, EBV recombinants containing a positive selection marker were identified and cloned in B-lymphoma (BL) cells infected and then plated under selective conditions (F. Wang, A. Marchini, and E. Kieff, J. Virol. 65:1701-1709, 1991). We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Transformation, Viral
Share to Genetic Markers
Share to Herpesvirus 4, Human

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lymphoma, B-Cell

Share to Mutation

Share to Phosphotransferases

Share to Phosphotransferases (Alcohol Group Acceptor)

Share to Tumor Cells, Cultured

Source

Open in PubMed Open full text

Identifiers

PMID: 1313925
DOI: 10.1128/JVI.66.5.3214-3219.1992
PMCID: PMC241090

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A selectable marker allows investigation of a nontransforming Epstein-Barr virus mutant.PMID 1313925Read ↗

Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.Semantic proximity Read ↗

Propagation and recovery of intact, infectious Epstein–Barr virus from prokaryotic to human cellsSemantic proximity Read ↗

The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.Semantic proximity Read ↗

Immortalization of human primary B lymphocytes in vitro with DNA.Semantic proximity Read ↗

A comprehensive library of mutations of Epstein Barr virus.Semantic proximity Read ↗

Systematic analysis of Epstein-Barr virus genes and their individual contribution to virus production and compositionSemantic proximity Read ↗

The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization.Semantic proximity Read ↗

A first-generation packaging cell line for Epstein–Barr virus-derived vectorsSemantic proximity Read ↗

Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection.Semantic proximity Read ↗

Epstein-Barr virus recombinants with specifically mutated BCRF1 genes.Semantic proximity Read ↗

Infectious Epstein-Barr Virus Lacking Major Glycoprotein BLLF1 (gp350/220) Demonstrates the Existence of Additional Viral LigandsSemantic proximity Read ↗

Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.